Skip to main content

Coronavirus: Vaccination

Question for Department of Health and Social Care

UIN 79292, tabled on 22 November 2021

To ask the Secretary of State for Health and Social Care, when he expects the MHRA to license a covid-19 nasal vaccine; and whether approval of nasal vaccines will be fast-tracked in line with injectable covid-19 vaccines; and if he will make a statement.

This answer is the replacement for a previous holding answer.

Answered on

26 January 2022

Any route to approval of nasal vaccine treatments is subject to the developer seeking regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA is therefore unable to provide a timetable for the approval of a COVID-19 nasal vaccine, as information on products not approved for use in the United Kingdom is commercially and market-sensitive. As with all other COVID-19 vaccines, the MHRA will ensure a thorough and expedited assessment of any such medicine’s safety and efficacy before any authorisation.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.